Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

106.66 +1.16 (+1.10%)
Official Closing Price Updated: 7:00 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Boston Scientific Corp (NYSE:BSX) Shows Strong Growth and Positive Technical Setup
Boston Scientific (BSX) stock shows strong growth, profitability, and a bullish technical setup, making it a top pick for a combined analysis strategy. 
Via Chartmill
How Do Investors Really Feel About Boston Scientific?
 
Via Benzinga
1 Momentum Stock Worth Your Attention and 2 We Avoid
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
 
Via Benzinga
3 Biotech Catalysts Present Major Opportunity
Three promising biotech names stand out for potentially catalyzing drugs currently on the market or in development; here's why they may rally further. 
Via MarketBeat
Earnings Scheduled For July 23, 2025
 
Via Benzinga
Boston Scientific Corp (NYSE:BSX) Presents High-Probability Technical Breakout Setup
Boston Scientific (BSX) is a top technical breakout candidate with strong uptrend momentum and a high-quality consolidation pattern, signaling a potential near-term advance. 
Via Chartmill
Boston Scientific Corp (NYSE:BSX) Exhibits Strong Growth Momentum and Technical Breakout Setup
Boston Scientific (BSX) stock shows strong growth momentum with rising earnings and a bullish technical breakout setup for investors. 
Via Chartmill
1 Growth Stock Set to Flourishand 2 We Avoid
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. 
Via StockStory
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
 
Via Benzinga
1 Profitable Stock Worth Investigating and 2 Facing Challenges
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
Topics Economy
2 Reasons to Like BSX (and 1 Not So Much)
Boston Scientific has been treading water for the past six months, recording a small loss of 1.2% while holding steady at $104.10. The stock also fell short of the S&P 500’s 5.5% gain during that... 
Via StockStory
Topics Stocks
Boston Scientific Stock Hits A Record High, Consolidates. Prepping For Another Run?
Boston Scientific stock rose to a record high in July and then consolidated. Prepping For a fresh run higher? 
Via Investor's Business Daily
Topics ETFs
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue
The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths. Healthcare providers are advised to monitor patients closely. 
Via Benzinga
Topics Death
Q2 Medical Devices & Supplies - Diversified Earnings: Boston Scientific (NYSE:BSX) Earns Top Marks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Boston Scientific (NYSE:BSX)... 
Via StockStory
Boston Scientific Corp (NYSE:BSX) Emerges as a Top Growth Stock with Strong Technical Breakout Potential
Boston Scientific (BSX) emerges as a top growth stock with strong fundamentals and bullish technical patterns, signaling potential breakout gains. 
Via Chartmill
What's Driving the Market Sentiment Around Boston Scientific?
 
Via Benzinga
Boston Sci Q2 Revenue Up 23%
Via The Motley Fool
Topics Economy World Trade
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
Edwards Lifesciences beat Q2 estimates and raised its 2025 sales outlook as TAVR and TMTT segments drove double-digit revenue growth. 
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss Boston Scientific Stock
 
Via Benzinga
Stocks making big moves yesterday: Power Integrations, Booz Allen Hamilton, Wendy's, SentinelOne, and Boston Scientific
Check out the companies making headlines yesterday: 
Via StockStory
BSX Q2 Deep Dive: Cardiovascular Momentum, New Technologies, and Global Expansion Shape Outlook
Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 22.8% year on year to $5.06 billion. Guidance for next quarter’s... 
Via StockStory
Boston Sci Q2 Revenue Up 23 Percent
Via The Motley Fool
Topics Economy World Trade
Stocks Jump On Trump's Trade Deal Deluge Ahead Of Big Tech Earnings: What's Moving Markets Wednesday?
A wave of U.S. trade deals with key allies over the past 24 hours reignited Wall Street's rally and boosted investor risk appetite across global markets. 
Via Benzinga
Topics Government
Why Boston Scientific (BSX) Stock Is Up Today
Shares of medical device company Boston Scientific (NYSE:BSX) jumped 4.2% in the afternoon session after the company reported second-quarter financial results that surpassed Wall Street expectations... 
Via StockStory
Boston Scientific Reports Higher Profit Margins In Q2, Lifts Guidance
Boston Scientific beats Q2 estimates, posts 22.8% revenue growth, and raises full-year outlook on strong cardiovascular and MedSurg performance. 
Via Benzinga
Boston Scientific Eyes Breakout On Strong Second Quarter, Guidance
The company issued a positive outlook for 2025 that includes better-than-expected sales growth and adjusted profit. 
Via Investor's Business Daily
Boston Scientific (NYSE:BSX) Reports Bullish Q2, Guides for Strong Sales Next Quarter
Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 22.8% year on year to $5.06 billion. Guidance for next quarter’s... 
Via StockStory
What To Expect From Boston Scientific’s (BSX) Q2 Earnings
Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday before market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.